WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 6 fonti

Experimental hepatitis B drug may offer ‘functional cure’

A first-of-its-kind drug for hepatitis B is allowing some patients to stop treatment without showing signs of the dangerous liver virus, in what is called a “functional cure”, researchers reported on Thursday.In two international studies, about one in five patients given the experimental drug saw their virus reduced to levels low enough for the immune system to keep it in check.

Raccontata dapbs.orgsciencealert.comlanacion.com.armedicalxpress.comgizmodo.comjamaica-gleaner.com

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
jamaica-gleaner.comStai leggendo2 g fa

Experimental hepatitis B drug may offer ‘functional cure’

A first-of-its-kind drug for hepatitis B is allowing some patients to stop treatment without showing signs of the dangerous liver virus, in what is called a “functional cure”, researchers reported on Thursday.In two…

originale

Timeline cronologica

  1. giovedì 28 maggio 2026·pbs.org

    Hepatitis B drug may offer 'functional cure' for some patients

    Researchers reported Thursday that in two international studies, about 1 in 5 patients given the experimental drug for six months saw their virus reduced to levels low enough that…

  2. venerdì 29 maggio 2026·sciencealert.com

    New Drug Offers 'Functional Cure' For Dangerous Liver Virus

    WASHINGTON (AP) – A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver virus, what's called a "functional…

pbs.org
5 g fa

Hepatitis B drug may offer 'functional cure' for some patients

Researchers reported Thursday that in two international studies, about 1 in 5 patients given the experimental drug for six months saw their virus reduced to levels low enough that the immune system could keep it in…

Leggi questa versione → originale
sciencealert.com4 g fa

New Drug Offers 'Functional Cure' For Dangerous Liver Virus

WASHINGTON (AP) – A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver virus, what's called a "functional cure," researchers reported Thursday.

Leggi questa versione → originale
gizmodo.com4 g fa

Experimental Drug May Offer a 'Functional Cure' for Some People with Chronic Hepatitis B

Across two large trials, roughly 20% of people treated with bepirovirsen had undetectable levels of the virus after stopping all treatment.

Leggi questa versione → originale
lanacion.com.ar4 g fa

Avance clave contra la hepatitis B: por primera vez, un tratamiento logra una remisión sostenida sin…

La mayoría de las personas se recupera de la infección, pero esta representa grandes riesgos para quienes no lo hacen; un fármaco experimental podría ser una solución para el 20% de estos pacientes

Leggi questa versione → originale
medicalxpress.com4 g fa

One in five patients achieve functional hepatitis B cure after 24 weeks of bepirovirsen

In an editorial published in the New England Journal of Medicine, University of Michigan Health hepatologist Anna S. Lok, M.D., hails newly announced results of the B-Well clinical trials as "a major step toward a…

Leggi questa versione → originale
  • venerdì 29 maggio 2026·lanacion.com.ar

    Avance clave contra la hepatitis B: por primera vez, un tratamiento logra una remisión sostenida sin medicación

    La mayoría de las personas se recupera de la infección, pero esta representa grandes riesgos para quienes no lo hacen; un fármaco experimental podría ser una solución para el 20%…

  • venerdì 29 maggio 2026·medicalxpress.com

    One in five patients achieve functional hepatitis B cure after 24 weeks of bepirovirsen

    In an editorial published in the New England Journal of Medicine, University of Michigan Health hepatologist Anna S. Lok, M.D., hails newly announced results of the B-Well…

  • venerdì 29 maggio 2026·gizmodo.com

    Experimental Drug May Offer a 'Functional Cure' for Some People with Chronic Hepatitis B

    Across two large trials, roughly 20% of people treated with bepirovirsen had undetectable levels of the virus after stopping all treatment.

  • domenica 31 maggio 2026·jamaica-gleaner.com

    Experimental hepatitis B drug may offer ‘functional cure’

    A first-of-its-kind drug for hepatitis B is allowing some patients to stop treatment without showing signs of the dangerous liver virus, in what is called a “functional cure”,…